Valley Brook Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.89M Buy
1,630
+5
+0.3% +$5.9K 1.06% 31
2026
Q2
$1.95M Buy
1,625
+75
+5% +$76.6K 1.11% 27
2026
Q1
$1.43M Buy
1,550
+20
+1% +$20.3K 0.96% 34
2025
Q4
$1.64M Sell
1,530
-157
-9% -$150K 1.09% 27
2025
Q3
$1.29M Buy
1,687
+85
+5% +$63.3K 0.87% 31
2025
Q2
$1.25M Buy
1,602
+20
+1% +$15.5K 0.93% 29
2025
Q1
$1.31M Buy
1,582
+45
+3% +$37.4K 1.03% 30
2024
Q4
$1.19M Sell
1,537
-10
-0.6% -$8.28K 0.89% 33
2024
Q3
$1.37M Buy
1,547
+83
+6% +$74.6K 0.98% 31
2024
Q2
$1.33M Buy
1,464
+106
+8% +$84.8K 1.03% 28
2024
Q1
$1.06M Buy
1,358
+47
+4% +$33.4K 0.84% 40
2023
Q4
$764K Buy
1,311
+40
+3% +$23.3K 0.67% 48
2023
Q3
$683K Hold
1,271
– – 0.67% 50
2023
Q2
$596K Sell
1,271
-230
-15% -$96.5K 0.55% 56
2023
Q1
$515K Hold
1,501
– – 0.48% 59
2022
Q4
$549K Hold
1,501
– – 0.53% 55
2022
Q3
$485K Hold
1,501
– – 0.53% 53
2022
Q2
$486K Hold
1,501
– – 0.5% 56
2022
Q1
$429K Hold
1,501
– – 0.37% 71
2021
Q4
$414K Hold
1,501
– – 0.36% 71
2021
Q3
$346K Hold
1,501
– – 0.34% 74
2021
Q2
$344K Sell
1,501
-25
-2% -$5.02K 0.33% 78
2021
Q1
$285K Buy
1,526
+25
+2% +$4.89K 0.26% 83
2020
Q4
$253K Buy
+1,501
New +$224K 0.25% 85

Other funds holding LLY

Valley Brook Capital Group's LLY Position: Q3 2026 in Review

Valley Brook Capital Group increased its Eli Lilly (LLY) stake by 0.31% in Q3 2026, buying an estimated $5.9K and bringing the position to 1,630 shares worth $1.89M. The position accounts for 1.06% of the portfolio, ranked #31.

Valley Brook Capital Group first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.95M in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Valley Brook Capital Group held 1,630 shares of Eli Lilly worth $1.89M as of Q3 2026.
  • Valley Brook Capital Group bought 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
  • Eli Lilly made up 1.06% of Valley Brook Capital Group's portfolio in Q3 2026, its #31 holding.
  • Valley Brook Capital Group first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
  • Valley Brook Capital Group's Eli Lilly position peaked at $1.95M in Q2 2026.
  • 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Valley Brook Capital Group's 13F filing for Q3 2026, filed 26 Oct 2026.